Animals, grouping, and dose administration

SS Shivangi Sharma
KV Kontham Kulangara Varsha
UR Ujjayinee Ray
HS Humaira Siddiqua
AJ Anjana Elizabeth Jose
SM Sridhar Muninarasimaiah
SR Sathees C. Raghavan
BC Bibha Choudhary
request Request a Protocol
ask Ask a question
Favorite

Wistar rats, Rattus norvegicus (~ 175 g) were purchased from Central Animal Facility, IISc, Bangalore. All the animals were housed in polypropylene cages and kept in controlled lighting of 12 h light/dark cycle throughout the experiment. Standard pellet diet (Agro Corporation Pvt. Ltd. India) and water ad libitum have been provided to the animals. Maintenance and handling of the animals were according to the guidelines of the animal ethical committee. The experimental design and methods followed institutional guidelines and were approved by Institutional Animal Ethics Committee of Indian Institute of Science, Bangalore (Ethical committee approval No: CAF/Ethics/551/2017 and CAF/Ethics/744/2020).

All the studies were designed according to the guidelines of the Central Drug Standard Control Organization (Schedule-Y-CDSCO, Appendix III), India (https://cdsco.gov.in/opencms/opencms/en/Drugs/New-Drugs/). Single-dose toxicity analysis was performed in male Wistar rats. Animals were segregated in groups of five, and Disarib was administered using oral gavage (100, 1000, 2000 mg/kg b. wt.). Carboxymethyl cellulose, used for preparing Disarib, served as vehicle control to feed control animals. Mortality, general appearance, and behavior were initially observed for 24 h. Animals were further observed for 14 days and were further subjected to toxicity analysis.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A